| Year |
Citation |
Score |
| 2014 |
Schultes BC, Chu CL, Long A, Sun E, Kurtagic E, Beccati D, Pradines J, Miller P, Ryan DP, Flaherty K, Roach J, Kaundinya GV. The effect and mechanism of M402 on gemcitabine uptake into pancreatic tumors. Journal of Clinical Oncology. 32: 215-215. DOI: 10.1200/jco.2014.32.3_suppl.215 |
0.733 |
|
| 2012 |
Chu CL, Long A, Duffner J, Holte K, Schultes BC. Role of M402, a novel heparan sulfate mimetic, in pancreatic cancer cell invasion and metastasis: Inhibition of the Sonic Hedgehog pathway and heparanase activity. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 25. PMID 28142431 DOI: 10.1200/jco.2012.30.30_suppl.25 |
0.346 |
|
| 2012 |
Fannon M, Forsten-Williams K, Zhao B, Bach E, Parekh PP, Chu CL, Goerges-Wildt AL, Buczek-Thomas JA, Nugent MA. Facilitated diffusion of VEGF165 through descemet's membrane with sucrose octasulfate. Journal of Cellular Physiology. 227: 3693-700. PMID 22378222 DOI: 10.1002/Jcp.24077 |
0.681 |
|
| 2012 |
Schultes BC, Lolkema MP, Chu CL, Zhou H, Long A, Lockley M, Avery W, Kurtagic E, Galcheva-Gargova Z, Miller P, Duffner J, Maschek BJ, Jarlenski D, Tuveson DA, Roach J, et al. M402, a heparan sulfate mimetic and novel candidate for the treatment of pancreatic cancer. Journal of Clinical Oncology. 30: 4056-4056. DOI: 10.1200/Jco.2012.30.15_Suppl.4056 |
0.737 |
|
| 2011 |
Zhou H, Roy S, Cochran E, Zouaoui R, Chu CL, Duffner J, Zhao G, Smith S, Galcheva-Gargova Z, Karlgren J, Dussault N, Kwan RY, Moy E, Barnes M, Long A, et al. M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis. Plos One. 6: e21106. PMID 21698156 DOI: 10.1371/Journal.Pone.0021106 |
0.313 |
|
| 2008 |
Forsten-Williams K, Chu CL, Fannon M, Buczek-Thomas JA, Nugent MA. Control of growth factor networks by heparan sulfate proteoglycans. Annals of Biomedical Engineering. 36: 2134-48. PMID 18839312 DOI: 10.1007/S10439-008-9575-Z |
0.71 |
|
| 2008 |
Fannon M, Forsten-Williams K, Nugent MA, Gregory KJ, Chu CL, Goerges-Wildt AL, Panigrahy D, Kaipainen A, Barnes C, Lapp C, Shing Y. Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth. Journal of Cellular Physiology. 215: 434-41. PMID 18163458 DOI: 10.1002/Jcp.21327 |
0.763 |
|
| 2005 |
Chu CL, Goerges AL, Nugent MA. Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. Biochemistry. 44: 12203-13. PMID 16142919 DOI: 10.1021/Bi050241P |
0.735 |
|
| 2004 |
Buczek-Thomas JA, Lucey EC, Stone PJ, Chu CL, Rich CB, Carreras I, Goldstein RH, Foster JA, Nugent MA. Elastase mediates the release of growth factors from lung in vivo. American Journal of Respiratory Cell and Molecular Biology. 31: 344-50. PMID 15191913 DOI: 10.1165/Rcmb.2003-0420Oc |
0.731 |
|
| 2004 |
Chu CL, Buczek-Thomas JA, Nugent MA. Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism. The Biochemical Journal. 379: 331-41. PMID 14717658 DOI: 10.1042/Bj20031082 |
0.784 |
|
| 2002 |
Buczek-Thomas JA, Chu CL, Rich CB, Stone PJ, Foster JA, Nugent MA. Heparan sulfate depletion within pulmonary fibroblasts: implications for elastogenesis and repair. Journal of Cellular Physiology. 192: 294-303. PMID 12124775 DOI: 10.1002/jcp.10135 |
0.757 |
|
| Show low-probability matches. |